News Sinco Pharmaceuticals Holdings Limited

Equities

6833

KYG8154Y1052

Market Closed - Hong Kong S.E. Other stock markets 04:08:58 2024-07-11 am EDT			5-day change	1st Jan Change
0.232 ^HKD	0.00%		-4.53%	-3.33%

Mar. 26	Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 26	Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sinco Pharmaceuticals Holdings Limited Approves Dividend for the Year Ended 31 December 2023	May. 16	CI
Sinco Pharmaceuticals' 2023 Profit Declines on Higher Tax Payments	Mar. 26	MT
Sinco Pharmaceuticals Holdings Limited Proposes Final Cash Dividend for the Year Ended 31 December 2023, Payable on 04 June 2024	Mar. 26	CI
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director	Mar. 26	CI
Sinco Pharmaceuticals Warns of Lower 2023 Profit	Mar. 13	MT
Sinco Pharmaceuticals Holdings Limited Provides Consolidated Earning Guidance for the Year Ended 31 December 2023	Mar. 13	CI
Sinco Pharmaceuticals Holdings Limited(SEHK:6833) dropped from S&P Global BMI Index	23-09-18	CI
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Sinco Pharmaceuticals Warns of 68% Drop in H1 Profit	23-08-16	MT
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023	23-08-16	CI
Sinco Pharma Taps Moore Advisory Services for Internal Control Review	23-05-01	MT
Sinco Pharmaceuticals Co-CEO Resigns; Shares Slip 3%	23-03-30	MT
Sinco Pharmaceuticals Holdings Limited Announces Final Dividend for the Year Ended 31 December 2022, Payable on June 15, 2023	23-03-29	CI
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Sinco Pharmaceuticals Holdings Limited Announces Chief Executive Officer Changes	23-03-29	CI
Sinco Pharmaceuticals Holdings Limited Appoints Lei Shifeng as Executive Director, with Effect from 29 March 2023	23-03-29	CI
Sinco Pharmaceuticals Expects 50% Drop in 2022 Profit; Shares Slip 4%	23-03-16	MT
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	23-03-15	CI
Sinco Pharmaceuticals Holdings Limited completed the acquisition of Deyang Demei Medical Aesthetic Clinic from Jiang Biao, Jiang Min and Jiang Jun.	22-12-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sinco Pharmaceuticals Holdings Limited

Equities

6833

KYG8154Y1052

Summary

Filters